Biotime-Nasdaq's best kept secret? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret?

BTIM 0.0001000

0.0%

Nov 5 1:26 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Stephen How who wrote (1011)	6/11/1998 9:02:00 AM
From: Jim Roof	Read Replies (1) of 1432

Just what is your position on BTIM today? Rather than post links to your page just make it a little easier on us and put it into your own words. This article seems to say that it is the molecular weight of the starch that is the beneficial factor yet that explanation fails to explain why there are observable differences between the generics and Hextend. Steve, do you realize that Biotime stumbled across Hextend? They were doing cryogenics and needed a solution that would better preserve organ tissues while undergoing the freezing process and hence they developed Hextend. It is my understanding that their primary goal was not to develop and market a blood volume expander. If you think about it, Biotime is a stupid name for a blood volume expander company but it makes perfect sense for a cryogenics firm. Also, as you already know, the founders come from a cryogenics background. All this to make a simple point. Biotime needed a better solution for their own work and developed Hextend (or something similar to it). I believe that the subsequent development of Hextend was merely the offshoot of Biotime's research into solving a cryomedical problem and this lends support to those of us who a.) believe that it is a better product and b.) do not believe as Bill Wexler does, that Biotime is a stock scam. BTW, Bill (I guess you search all text for your name to see what kind of broad impact your wisdom has on the markets), I still see no insiders selling - in fact, they are buying. This fact befuddles your claim of 'pump and dump' fraud. The stock surely did pump but the dump by insiders never happened. I know that this is extremely corollary information but one would wonder why Biotime would not use hespan for their own work if it were as good as Hextend. Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next